Acadia director granted 6,331 ACHC shares
Fucci Michael reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Fucci Michael reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Michael Fucci received a grant of 6,331 shares of common stock as compensation. The shares were awarded at no cash cost to him and will vest over a three-year period in equal yearly installments beginning on May 6, 2027. After this grant, he directly holds a total of 28,152 shares of Acadia Healthcare common stock. This is a routine equity award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 6,331 | $0.00 | $0.00 |
Footnotes (1)
- F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
Key Figures
Key Terms
Grant, award, or other acquisition financial
vesting financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ACHC director Michael Fucci report on this Form 4?
Is Michael Fucci’s ACHC Form 4 transaction a stock purchase or a grant?
What is the vesting schedule for Michael Fucci’s new ACHC stock award?
Does the ACHC Form 4 show any stock sales by Michael Fucci?
AI-generated analysis. How Rhea-AI works. Not financial advice.